Drug Database
Back to search

Belgium· BE-AMP-SAM163256-00

Nevrine Codeine

A codein, kombinationen mit psycholeptika (codein monopräparate siehe r05da04) product containing caffeine, registered in Belgium by Laboratoires Sterop. The same ATC class is registered in 2 of our 19 countries.

ATC N02AA79

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedNevrine CodeineATCN02AA79REGISTER NO.BE-AMP-SAM163256-00PACKS LISTED1CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about caffeineAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Codein, kombinationen mit psycholeptika (codein monopräparate siehe r05da04) is registered in 2 of 19 countries.

Countries holding a registration under ATC N02AA79 (codein, kombinationen mit psycholeptika (codein monopräparate siehe r05da04)), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 1 of them publish a price we can compare per daily dose
Search codein, kombinationen mit psycholeptika (codein monopräparate siehe r05da04) products by name

Codein, kombinationen mit psycholeptika (codein monopräparate siehe r05da04) · ATC N02AA79

2 / 19 countries

  • Belgiumprice
  • Canada
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Caffeine
Manufacturer
Laboratoires Sterop
Country
Belgium (BE)
ATC code
N02AA79
ATC class
Codein, Kombinationen mit Psycholeptika (Codein Monopräparate siehe R05DA04)
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 1

  • be_apb
    2511541

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

2 interactions on record for codein, kombinationen mit psycholeptika (codein monopräparate siehe r05da04).

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check codein, kombinationen mit psycholeptika (codein monopräparate siehe r05da04) against other medicinesHow interaction checks work

Codein, kombinationen mit psycholeptika (codein monopräparate siehe r05da04) · interactions on record

2 records

2 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Codein, kombinationen mit psycholeptika (codein monopräparate siehe r05da04) in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All codein, kombinationen mit psycholeptika (codein monopräparate siehe r05da04) products

Authorised across Europe · EMA

The same active substance is authorised in 12 EEA countries. Names it is sold under:

  • Austria · Coffekapton
  • Germany · Coffeinum N, Percoffedrinol N Aristo
  • Spain · Durvitan
  • France · Citrate De Cafeine Cooper, Percutafeine
  • United Kingdom (Northern Ireland) · Caffeine Citrate, Caffeine Citrate Brown & Burk Uk
  • Hungary · Coffeini Fono Viii. Naturland
  • Iceland · Gencebok, Peyona
  • Italy · Caffeina Citrato Monico
  • Liechtenstein · Gencebok, Peyona
  • Malta · Caffeine Citrate Monico
  • Norway · Gencebok, Peyona
  • Sweden · Koffein Viatris

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/fc2a024f-44ae-4db0-8fa5-c6bad86a2768
GET /v1/drugs/fc2a024f-44ae-4db0-8fa5-c6bad86a2768?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablet",
  "source": "afmps",
  "status": "REVOKED",
  "name_en": "Nevrine Codeine",
  "name_fr": "Nevrine Codeine",
  "name_nl": "Nevrine Codeine",
  "amp_code": "SAM163256-00",
  "strengths": [
    "50.0000",
    "50.0000",
    "500.0000",
    "500.0000",
    "30.0000",
    "30.0000",
    "0.0600",
    "10.0000"
  ],
  "pack_count": 2,
  "substances": [
    "Caffeine",
    "Paracetamol",
    "Codeine Phosphate Hemihydrate",
    "E 124",
    "Sodium Starch Glycolate (Type A)"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Codeine, Combinations with Psycholeptics",
  "authorisation_numbers": [
    "BE163256"
  ]
}
API referenceMCP serverPlans

See everything about codein, kombinationen mit psycholeptika (codein monopräparate siehe r05da04).

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console